Men who undergo external-beam radiation therapy (EBRT) for prostate cancer may develop a number of side effects, most notably erectile dysfunction (ED) and urinary problems. However, lesser-known side effects, such as issues with orgasm, need attention as well, according to new research.
After radical prostatectomy, many men experience a temporary shortening of the penis. But they could regain most of that length, if not all, within a year, according to new research.
Phosphodiesterase type 5 (PDE5) inhibitors, which are prescribed to treat erectile dysfunction (ED), do not appear to reduce the risk of developing prostate cancer, according to new research published in the Journal of Urology.
Testosterone replacement therapy (TRT) does not appear to increase a man’s risk for aggressive prostate cancer, according to a team of American and Swedish researchers.
Does restoration of erectile function after prostate cancer surgery equal overall sexual satisfaction? Not necessarily, according to a new study in the Journal of Sexual Medicine.
Prostate cancer affects gay and bisexual (GB) men in different ways than their heterosexual counterparts, according to a new study in the Journal of Sexual Medicine.